145 related articles for article (PubMed ID: 38606818)
1. Clinical characterization of hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors: a review of published cases.
Xu Z; Li H; Yu X; Luo J; Zhang Z
Hematology; 2024 Dec; 29(1):2340144. PubMed ID: 38606818
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics, treatment, and management of pembrolizumab induced hemophagocytic lymphohistiocytosis.
Wang C; Sun W; Li Z; Wu T; Fang W
Invest New Drugs; 2023 Dec; 41(6):834-841. PubMed ID: 37897650
[TBL] [Abstract][Full Text] [Related]
3. Two cases of lung cancer with hemophagocytic lymphohistiocytosis caused by immune checkpoint inhibitors.
Kurozumi A; Takahashi H; Watanabe T; Iwasaki Y
Thorac Cancer; 2021 May; 12(10):1625-1628. PubMed ID: 33783978
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the clinical characteristics of lamotrigine-induced haemophagocytic lymphohistiocytosis.
Wang C; Fan Z; He Y; Fang W; Sun W; Li Z
J Clin Pharm Ther; 2022 Jun; 47(6):745-751. PubMed ID: 35023173
[TBL] [Abstract][Full Text] [Related]
5. Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report.
Sadaat M; Jang S
J Immunother Cancer; 2018 Jun; 6(1):49. PubMed ID: 29871698
[TBL] [Abstract][Full Text] [Related]
6. [Hemophagocytic lymphohistiocytosis caused by hematogenous disseminated pulmonary tuberculosis: A case report].
Li QY; Liang Y; Dai NN; Wang YX; Zhu BT; Wu R; Zhu H; Sun YC
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1219-1223. PubMed ID: 36533359
[TBL] [Abstract][Full Text] [Related]
7. Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports.
Noseda R; Bertoli R; Müller L; Ceschi A
J Immunother Cancer; 2019 May; 7(1):117. PubMed ID: 31046841
[TBL] [Abstract][Full Text] [Related]
8. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults.
Tseng YT; Sheng WH; Lin BH; Lin CW; Wang JT; Chen YC; Chang SC
J Microbiol Immunol Infect; 2011 Jun; 44(3):191-7. PubMed ID: 21524613
[TBL] [Abstract][Full Text] [Related]
9. Hemophagocytic Lymphohistiocytosis Secondary to Immune Checkpoint Inhibitor Therapy.
Rajapakse P; Andanamala H
World J Oncol; 2022 Apr; 13(2):49-52. PubMed ID: 35571340
[TBL] [Abstract][Full Text] [Related]
10. Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients.
Nyvlt P; Schuster FS; Ihlow J; Heeren P; Spies C; Hiesgen J; Schenk T; von Brünneck AC; Westermann J; Brunkhorst FM; La Rosée P; Janka G; Lachmann C; Lachmann G
Eur J Haematol; 2024 Jun; 112(6):917-926. PubMed ID: 38368850
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy Rechallenge After Checkpoint Inhibitor Induced Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review.
Geusens D; Dierickx D; Carton S; Van Cutsem E; Dekervel J
Clin Colorectal Cancer; 2024 Jun; 23(2):194-197. PubMed ID: 38519390
[No Abstract] [Full Text] [Related]
12. Hemophagocytic lymphohistiocytosis with advanced malignant melanoma accompanied by ipilimumab and nivolumab: A case report and literature review.
Mizuta H; Nakano E; Takahashi A; Koyama T; Namikawa K; Yamazaki N
Dermatol Ther; 2020 May; 33(3):e13321. PubMed ID: 32191382
[TBL] [Abstract][Full Text] [Related]
13. Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review.
Zhai C; Jin X; You L; Yan N; Dong J; Qiao S; Zhong Y; Zheng Y; Pan H
BMC Geriatr; 2024 Jan; 24(1):32. PubMed ID: 38191289
[TBL] [Abstract][Full Text] [Related]
14. Hemophagocytic lymphohistiocytosis (HLH) and cytokine release syndrome (CRS) in a patient with oncogene-addicted metastatic non-small cell lung cancer (NSCLC) following combination chemotherapy-immunotherapy.
Heynemann S; Vanguru V; Adelstein S; Kao S
Asia Pac J Clin Oncol; 2024 Apr; 20(2):315-318. PubMed ID: 36562695
[TBL] [Abstract][Full Text] [Related]
15. Hemophagocytic histiocytosis in severe SARS-CoV-2 infection: A bone marrow study.
Dandu H; Yadav G; Malhotra HS; Pandey S; Sachu R; Dubey K
Int J Lab Hematol; 2021 Dec; 43(6):1291-1301. PubMed ID: 34086418
[TBL] [Abstract][Full Text] [Related]
16. Hemophagocytic Lymphohistiocytosis and Bone Marrow Hemophagocytosis: A 5-Year Institutional Experience at a Tertiary Care Hospital.
Lao K; Sharma N; Gajra A; Vajpayee N
South Med J; 2016 Oct; 109(10):655-660. PubMed ID: 27706506
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
Soy M; Atagündüz P; Atagündüz I; Sucak GT
Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
[TBL] [Abstract][Full Text] [Related]
18. Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab.
Hantel A; Gabster B; Cheng JX; Golomb H; Gajewski TF
J Immunother Cancer; 2018 Jul; 6(1):73. PubMed ID: 30012206
[TBL] [Abstract][Full Text] [Related]
19. Immune checkpoint inhibitor-associated hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemia.
Ali SB; Kuss B; Karapetis C; Hughes T; Smith A
Immunotherapy; 2023 Dec; 15(18):1531-1537. PubMed ID: 37933523
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and non-malignancy-induced hemophagocytic lymphohistiocytosis.
Lim SH; Park S; Jang JH; Kim K; Kim HJ; Kim SH; Kang CI; Chung DR; Peck KR; Lee J; Cha HS; Koh EM; Ko YH; Kim WS; Jung CW; Kim SJ
Ann Hematol; 2016 Jan; 95(2):325-35. PubMed ID: 26453074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
